Jakob Schöllhammer Knudsen (Jakob S Knudsen)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 8

Top Topics

Cross Sectional

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Hanan Amadid, Pernille F Rønn, Maria Bekker-Nielsen Dunbar, Jakob Schöllhammer Knudsen, Bendix Carstensen, Frederik Persson, Marit E Jørgensen
A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study. Diabetes, obesity & metabolism 23 (10) (2021)
Mads Bisgaard Bengtsen, Jakob Schöllhammer Knudsen, Maria Bisgaard Bengtsen, Niels Møller, Reimar Wernich Thomsen
Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA1c and glucose-lowering drug use before and after hypoglycaemia. Endocrinology, diabetes & metabolism 4 (3) (2021)
Jakob Schöllhammer Knudsen, Lisbeth M Baggesen, Maria Lajer, Larisa Nurkanovic, Anastasia Ustyugova, Henrik T Sørensen, Reimar Wernich Thomsen
Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study. PloS one 15 (3) (2020)
Kristian Løkke Funck, Jakob Schöllhammer Knudsen, Troels Krarup Hansen, Reimar Wernich Thomsen, Erik Lerkevang Grove
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019. Diabetes, obesity & metabolism 23 (2) (2020)
Jakob Schöllhammer Knudsen, Reimar W Thomsen, Anton Pottegård, Filip K Knop, Henrik T Sørensen
Clinical characteristics and glucose-lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study. Journal of diabetes 11 (8) (2019)
Jakob Schöllhammer Knudsen, Adam Hulman, Pernille F Rønn, Torsten Lauritzen, Henrik T Sørensen, Daniel R Witte, Reimar Wernich Thomsen
Trends in HbA1c and LDL Cholesterol in Patients With Type 2 Diabetes Receiving First-Time Treatment in Northern Denmark, 2000-2017: Population-Based Sequential Cross-Sectional Analysis. Diabetes care 43 (2) (2019)
Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen
Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide. Diabetes care 41 (9) (2018)
Morten Laursen, Lilliana Beck, Jan Kehler, Claus Tornby Christoffersen, Christoffer Bundgaard, Susie Mogensen, Tomas Joachim Mow, Estéfano Pinilla, Jakob Schöllhammer Knudsen, Elise Røge Hedegaard, Morten Grunnet, Ulf Simonsen
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats. British journal of pharmacology 174 (15) (2017)